BRIDGET WAREHAM: Open Payments
NPI 1639636905 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 18 payments from 9 companies in 2025. Trend: 2023 $410 · 2024 $654 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $143 |
| Astellas Pharma US Inc | 1 | $99 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Amgen Inc. | 2 | $61 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| PFIZER INC. | 2 | $41 |
| SANOFI PASTEUR INC. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: Ozempic, Veozah, EVENITY, ROTATEQ, PENMENVY, BEXSERO, Wegovy, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
